Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure

Zhang, Xiangyu; Xiong, Yi; Xia, Qing; Wu, Fang; Liu, Lingli; Zhou, Yuling; Zeng, Liang; Zhou, Chunhua; Xia, Chen; Jiang, Wenjuan; Liao, Dehua; Xiao, Lili; Liu, Li; Yang, Haiyan; Guan, Rui; Li, Kunyan; Wang, Jing; Lei, Guang; Zhang, Yongchang; Yang, Nong

Published in

JAMA Network Open, 3(3), p. e201226, 2020

DOI: 10.1001/jamanetworkopen.2020.1226

Tools

Export citation

Search in Google Scholar

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure

Journal article published in 2020 by Xiangyu Zhang, Yi Xiong, Qing Xia, Fang Wu, Lingli Liu, Yuling Zhou, Liang Zeng, Chunhua Zhou, Chen Xia, Wenjuan Jiang, Dehua Liao, Lili Xiao, Li Liu, Haiyan Yang, Rui Guan and other authors.

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure